Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q4 2022 Earnings Call Transcript

Page 7 of 14

Ivan Tornos: Yes, I can take that as well. We’ve been in the low teens, as we’ve been disclosing. That’s obviously prior to the launch of Persona OsseoTi, which is now in the market, it’s been around for two weeks. The expectation is that number is going to dramatically increase, and as you know, Drew, in combination with robotics, you’re going to see a collateral effect. You’re going to see increase of cementless mix, you’re going to see an increase of robotics penetration, so we’re already bullish about where we’re going to end at the end of the year. We don’t disclose that externally, but you should expect something fairly aggressive.

Bryan Hanson: Just to make sure no one’s confused, Persona OsseoTi, we’ve not used the name before, but that is the new form factor for cementless for Persona.

Drew Ranieri: Thank you.

Keri Mattox: Thanks Drew. Katie, can we go to the next question in the queue?

Operator: We’ll go next to Josh Jennings with Cowen.

Josh Jennings: Hi, good morning. Thanks for taking the questions. I was hoping, Bryan, to ask you–you teed up the question for us on price, and Suke, and just maybe a recap of how you fared in ’22. I’m not sure if you quantified pricing assumptions and guidance top line for ’23, but maybe if you could also just directionally help us out, figure out the difference in terms of the pricing environment in the U.S. versus Europe and Asia-Pac.

Suketu Upadhyay: Sure, I’ll take that. First of all, thanks for the question, Josh. On pricing, we had a really good fourth quarter. If you look at our disclosure, our press release, you’d actually see that pricing is positive in the fourth quarter. Now, I would say on an underlying basis, pricing had erosion of about 100 to 150 basis points. We benefited by some year-over-year comps due to BBP, and we also had some one-time pull adjustments that were favorable in the quarter that drove us to be positive in the fourth quarter. But on an underlying basis, I would still think about it as 100 to 150 basis points erosion, which is still incredibly good versus our historical average of 200 to 300 basis points. We ended the year at about 150 basis points of erosion, again, so a pretty clear step change to where we’ve been historically.

I talked about in my scripted remarks, we expect next year–or this year, I should say, 2023 to be slightly better than that annual average that we had before 2022, so maybe not as good as ’22 but definitely better than where we’ve historically been. There are a number of drivers inside of that. Some of them are transitional, some are more structural in nature. The ones that I’m more excited about are those structural improvements that we’ve made. We’ve made a lot of investments around capabilities, around systems, around analytics. We’ve got better governance, we’ve got better discipline. It’s an area we incent the field force off of now, so there are a host of things that structurally are improving our price performance as we move to 2023, and that’s sticking and part of our guide.

If you think about the dynamics between U.S. and EMEA and Asia Pacific, maybe I’ll let Ivan talk a little bit about what he’s seeing.

Ivan Tornos: Thanks Suke. So far, we’re not seeing the performance when it comes to pricing being in a single region. Frankly, 2022, all three regions beat our expectations when it comes to pricing. The most important part, I do think it’s sustainable with the guidance that we’ve given for 2023. The role of innovation also is a critical component of the sustainability of that pricing. As you think about bundle deals, as you think about bringing innovation, that is going to drive mix and in some cases a bit of price performance.

Page 7 of 14